Brand

Abiomed

Abiomed makes mechanical circulatory support devices used in cardiogenic shock and high-risk coronary procedures. Johnson & Johnson's fiscal 2025 Form 10-K places it in the MedTech cardiovascular portfolio.

Medical devices Healthcare

Documented stakes

Johnson & JohnsonControlling stakeHigh confidence
The fiscal 2025 Form 10-K describes Abiomed as part of the MedTech cardiovascular portfolio. It does not restate a percentage.
As of Dec 28, 2025. Last checked Sep 22, 2026.
- Johnson & Johnson Form 10-K for the fiscal year ended December 28, 2025 · U.S. Securities and Exchange Commission